EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitKohortenstudie

Speed and Safety of IV Push Versus IV Piggyback Valproate Loading Doses: A Retrospective Cohort Study

Morgan Crawford iD, Riley Johnson, Andrew J Webb iD

Annals of Pharmacotherapy · 10.07.2026

DOI: 10.1177/10600280261459930 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of Pharmacotherapy, online erschienen am 10.07.2026. Verfasst von Morgan Crawford und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Massachusetts General Hospital, Boston, USA. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Delays in intravenous antiseizure medication (ASM) administration may worsen seizure outcomes. Intravenous push (IVP) administration reduces administration time for several ASMs, but evidence for IVP valproate loading is limited.

Objective

To compare time from pharmacist verification to documented administration for IVP versus intravenous piggyback (IVPB) valproate loading doses and compare adverse event frequencies.

Methods

This single-center retrospective study included adults from October 2023 to May 2025 who received an IV valproate loading dose (≥15 mg/kg). On August 15, 2024, institutional practice changed from IVPB valproate more than 60 minutes to undiluted IVP valproate at 500 mg/min. The primary outcome was time from pharmacist verification to loading dose administration. Secondary outcomes included order-to-administration time, adverse events, intensive care unit (ICU) admission, length of stay, and mortality.

Results

One hundred thirty-one patients met the inclusion criteria (IVP, n = 60; IVPB, n = 71). Median (interquartile range [IQR]) age was 63 years (44-71), and 85 (65%) patients were male. Valproate indications were witnessed seizure in 92 (70.2%), suspected seizure in 29 (22.1%), and agitation/psychiatric in 10 (7.6%). Sixty-four (48.8%) patients received loading doses for status epilepticus. The median (IQR) loading dose was 28 (20-34.5) mg/kg. Median time to administration was 36 (95% CI, 22-52) minutes shorter with IVP than with IVPB (median [IQR], 28 [13-48] vs 63 [50-84] minutes; P < 0.001). Cardiovascular events occurred in 38.3% and 27.8% of IVP and IVPB patients ( P = 0.27); sedation in 3.3% and 0% ( P = 0.20); and valproate-associated adverse events in 6.7% and 1.4% ( P = 0.18). No phlebitis or infiltration occurred. Conclusion and Relevance: Intravenous push valproate loading reduced time to administration without an observed increase in adverse events.

Schlagwörter

Stichwörter der Autor:innen

IV pushantiseizure medicationshazardous medicationintravenous administrationseizuresvalproate

Autor:innen und Institutionen

  • Department of Pharmacy, Massachusetts General Hospital, Boston, USA.

ORCID-Profile: Morgan Crawford, Andrew J Webb

Zitieren

APA

Crawford, M., Johnson, R., & Webb, A. J. (2026). Speed and Safety of IV Push Versus IV Piggyback Valproate Loading Doses: A Retrospective Cohort Study. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280261459930

Vancouver

Crawford M, Johnson R, Webb AJ. Speed and Safety of IV Push Versus IV Piggyback Valproate Loading Doses: A Retrospective Cohort Study. Annals of Pharmacotherapy. 2026. doi:10.1177/10600280261459930

BibTeX
@article{Crawford2026,
  author = {Crawford, Morgan and Johnson, Riley and Webb, Andrew J},
  title = {Speed and Safety of IV Push Versus IV Piggyback Valproate Loading Doses: A Retrospective Cohort Study},
  journal = {Annals of Pharmacotherapy},
  year = {2026},
  doi = {10.1177/10600280261459930}
}
Kostenlos starten →